EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study on the Threshold of Serum Ferritin Required for Erythropoiesis and Iron Sufficiency in Hemodialysis Patients

Chie Ogawa, Ken Tsuchiya, Taku Morito, Naohisa Tomosugi iD, Kunimi Maeda

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27041754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Chie Ogawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maeda Institute of Renal Research, Kawasaki 211-0063, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Iron, Ferritins, Erythropoiesis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum ferritin (Ft) reflects total body iron stores and serves as a reference indicator for iron supplementation. However, optimal Ft level remains unclear in hemodialysis (HD) patients. We previously reported that total body iron (TBI), a novel index defined as the sum of red blood cell iron and storage iron, increases during oral iron replacement therapy (OIRT) and remains stable once iron sufficiency is achieved. In this study, we analyzed data from 100 OIRT courses in 79 maintenance HD patients. We examined the relationship between changes in hemoglobin (Hb) and Ft (⊿Hb, ⊿Ft) at 4 and 7 months after the initiation of OIRT, during which TBI remained stable, to determine the Ft level required for erythropoiesis. At 7 months, compared with 4 months, mean Hb significantly decreased by 0.2 g/dL (p = 0.03), while median Ft significantly increased from 60 to 75.0 ng/mL (p < 0.01). After adjustment for TBI, a significant inverse relationship was observed between ⊿Hb and ⊿Ft (β = −35.9, 95% CI −40.1 to −31.7, p < 0.001). These results indicate that an increase of 1 g/dL in Hb requires approximately 30–40 ng/mL of Ft, suggesting that this threshold may be useful for guiding iron supplementation in the treatment of anemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisIronFerritinsErythropoiesisHumansFemaleHemoglobinsMaleMiddle AgedAged

Stichwörter der Autor:innen

ferritinhemodialysishemoglobinoral iron replacement therapy

Substanzen

IronFerritinsHemoglobins

Autor:innen und Institutionen

  • Maeda Institute of Renal Research, Kawasaki 211-0063, Japan.
  • Biomarker Society, Inc., Kawasaki 211-0063, Japan.
  • Department of Nephrology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
  • Division of Systems Bioscience for Drug Discovery Project Research Center, Medical Research Institute, Kanazawa Medical University, Kahoku 920-0293, Japan.

ORCID-Profile: Naohisa Tomosugi

Zitieren

APA

Ogawa, C., Tsuchiya, K., Morito, T., Tomosugi, N., & Maeda, K. (2026). Study on the Threshold of Serum Ferritin Required for Erythropoiesis and Iron Sufficiency in Hemodialysis Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041754

Vancouver

Ogawa C, Tsuchiya K, Morito T, Tomosugi N, Maeda K. Study on the Threshold of Serum Ferritin Required for Erythropoiesis and Iron Sufficiency in Hemodialysis Patients. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041754

BibTeX
@article{Ogawa2026,
  author = {Ogawa, Chie and Tsuchiya, Ken and Morito, Taku and Tomosugi, Naohisa and Maeda, Kunimi},
  title = {Study on the Threshold of Serum Ferritin Required for Erythropoiesis and Iron Sufficiency in Hemodialysis Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27041754}
}
Kostenlos starten →